RVP · Retractable Technologies Inc
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Aggregate dollar amount of net sales to significant customers | $3.5M | the three months ended June 30, 2026 filing | — |
| Domestic sales as percentage of total revenues | 81.6% | the three months ended June 30, 2026 filing | — |
| Domestic unit sales as percentage of total unit sales | 70.3% | the three months ended June 30, 2026 filing | — |
| Number of significant customers | 2 | the three months ended June 30, 2026 filing | — |
| Percentage of net sales to significant customers | 49.1% | the three months ended June 30, 2026 filing | — |
| Percentage of products obtained from Chinese manufacturers | 53.5% | the second quarter of 2026 filing | — |
| Realized gain from sale of equity | $6.4M | the second quarter of 2026 filing | — |
| Tariff expense | $46K | the second quarter of 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RVP
this stock
Retractable Technologies Inc
|
$21.85M | -5.2% | +15.8% | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$131.36B | -34.6% | +20.5% | 42.7 | 2.0% |
|
BDX
Becton Dickinson & Co
|
$51.81B | — | +8.2% | — | 3.4% |
|
MDLN
Medline Inc.
|
$46.36B | -17.7% | +11.5% | — | 2.8% |
|
ALC
Alcon Inc
|
$35.13B | -7.8% | +10.5% | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RVP | +1.4% | +8.9% | +4.3% | +10.6% | -5.2% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +1.8% | +3.9% | -8.2% | +8.0% | -17.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.